These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4114930)

  • 1. The complement system of man. I.
    Ruddy S; Gigli I; Austen KF
    N Engl J Med; 1972 Sep; 287(10):489-95. PubMed ID: 4114930
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation, activities and pharmacologically active products of complement.
    Vogt W
    Pharmacol Rev; 1974 Jun; 26(2):125-69. PubMed ID: 4609350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlation of complement system with coagulation, fibrinolysis, and kinin generation].
    Kondo M
    Rinsho Ketsueki; 1976 Jan; 17(1):1-14. PubMed ID: 135104
    [No Abstract]   [Full Text] [Related]  

  • 4. Hageman complement and factor.
    Kim Z
    Ann Allergy; 1977 Mar; 38(3):211-4. PubMed ID: 842908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
    Cochrane CG; Müller-Eberhard HJ; Aikin BS
    J Immunol; 1970 Jul; 105(1):55-69. PubMed ID: 4246566
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
    Brade V; Vogt W
    Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
    [No Abstract]   [Full Text] [Related]  

  • 7. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
    Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
    Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate complement pathways.
    Osler AG; Sandberg AL
    Prog Allergy; 1973; 17(0):51-92. PubMed ID: 4277357
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
    J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract]   [Full Text] [Related]  

  • 11. Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.
    Koethe SM; Austen KF; Gigli I
    J Immunol; 1973 Feb; 110(2):390-400. PubMed ID: 4684033
    [No Abstract]   [Full Text] [Related]  

  • 12. Hageman-factor-dependent coagulation, fibrinolysis, and kinin generation.
    Austen KF
    Transplant Proc; 1974 Mar; 6(1):39-45. PubMed ID: 4274038
    [No Abstract]   [Full Text] [Related]  

  • 13. Interrelationships of the fibrinolytic, coagulation, kinin generating and complement systems.
    Schreiber AD; Austen KF
    Ser Haematol; 1973; 6(4):593-600. PubMed ID: 4212102
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunobiology of complement.
    Burkholder PM; Littleton CE
    Pathobiol Annu; 1971; 1():215-39. PubMed ID: 4129958
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of endotoxic lipopolysaccharide-mediated platelet aggregation by cobra venom anticomplementary factor.
    Fong JS; White JG; Good RA
    Blood; 1974 Sep; 44(3):399-409. PubMed ID: 4604614
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of enzymes in inflammation].
    Fujii S; Muramatsu M
    Rinsho Byori; 1973 Jan; 21(1):1-10. PubMed ID: 4267648
    [No Abstract]   [Full Text] [Related]  

  • 17. [The third component of complement and complement receptors (author's transl)].
    Okuda T; Tachibana T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(9):657-67. PubMed ID: 4215099
    [No Abstract]   [Full Text] [Related]  

  • 18. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I; Koethe S; Austen KF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical applications of complement assays.
    Alper CA; Rosen FS
    Adv Intern Med; 1975; 20():61-88. PubMed ID: 46689
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement.
    Vogt W; Dieminger L; Lynen R; Schmidt G
    Hoppe Seylers Z Physiol Chem; 1974 Feb; 355(2):171-83. PubMed ID: 4215726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.